Achievement of Goal Resting Heart Rate on B-blockers in Patients With Stable Angina and Hypertension

Observational Non-interventional Study - Epidemiological Survey AchievemenT of Goal Resting HEart Rate on Beta-blockers in Patients With Stable angiNA and Hypertension in Routine Practice

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01321242

Acronym

Athena

Enrollment

400

Registered

2011-03-23

Start date

2011-04-30

Completion date

2011-08-31

Last updated

2012-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Stable Angina

Keywords

Resting heart rate, Stable Angina, Hypertension, beta-blockers

Brief summary

This is a multicenter survey of Russian data on target heart rate achievement in patients with stable angina and arterial hypertension who are currently treated with beta-blockers for at least 2 months and with no dose change for a minimum of 4 weeks

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Stable angina I-III class by the Canadian Cardiovascular Society Classification and concomitant primary hypertension * Subject is on beta-blockers treatment for at least 2 months prior to inclusion into survey, with no dose change for a minimum of 4 weeks

Exclusion criteria

* Use of phenylalkylamine and benzothiazepine calcium channel blockers * Hemodynamic significant mitral and aortic valve disease * Acute myocardial infarction and unstable angina within 3 months before enrolment

Design outcomes

Primary

Measure	Time frame	Description
Establish the proportion of patients with stable angina and hypertension on beta-blockers reaching the resting HR goals according to ACC/AHA/ACP-ASIM* Guidelines	1 visit within 5 month	\*American College of Cardiology (ACC)/American Heart Association (AHA)/American College of Physicians (ACP-ASIM)

Secondary

Measure	Time frame
Establish the mean dose of each beta-blocker in patients who achieved and not achieved resting HR goals	1 visit within 5 month
Compare quality of life in patients who achieved and non achieved resting HR goals	1 visit within 5 month
To estimate the correlation between achievement of resting HR goals according to ACC/AHA/ACP-ASIM Guidelines for the management of patients	1 visits within 5 month

Countries

Russia

Outcome results